Caldera Therapeutics: Funding, Investors & Team (Oct 2026)
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Caldera Therapeutics has raised $278M across 1 funding round on record, the most recent an undisclosed round of $278M announced in Jul 2026.
That round is above the $7.6M median round size for United States companies tracked on FundedIQ over the last two years.
Caldera Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Caldera Therapeutics Funding Rounds
Caldera Therapeutics Investors
11 investors are recorded in total; the 5 named above are those the record identifies.
Caldera Therapeutics Founders and Leadership Team
Contact details for the Caldera Therapeutics team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Caldera Therapeutics Funding in Context
Caldera Therapeutics' latest round of $278M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Caldera Therapeutics in Biopharma and Cambridge
Companies Similar to Caldera Therapeutics
Xact Bio is a biotechnology company that develops extra-hepatic siRNA delivery for RNA medicines.
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…
Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…
PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…
Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…
Insuraviews provides software for analyzing insurance rate filings with search, analytics, and competitive…
Thrixel is an AI-powered 3D model generation platform designed to integrate directly with coding agents, AI…
Vye Health is an AI-native healthcare company that provides tools for medical providers to launch and run…
Park Golf Pitch & Putt is a sports company that focuses on outdoor entertainment with focus on pitch-putt…
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Caldera Therapeutics Funding FAQs
What does Caldera Therapeutics do?
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
How much funding has Caldera Therapeutics raised?
Caldera Therapeutics has raised $278M across 1 round on record. The most recent is an undisclosed round of $278M announced in Jul 2026.
When did Caldera Therapeutics last raise funding?
Caldera Therapeutics' most recent funding round on record is an undisclosed round of $278M, announced in Jul 2026.
Who has invested in Caldera Therapeutics?
Investors on record for Caldera Therapeutics include Wellington Management, Vivo Capital, TCG Crossover, Janus Henderson Investors, Bain Capital Life Sciences. FundedIQ records 11 investors in total.
Who founded Caldera Therapeutics?
FundedIQ lists Aaron Pelta (Co-Founder and Chief Business Officer) at Caldera Therapeutics.
Who is the CEO of Caldera Therapeutics?
Praveen Tipirneni is listed as Chief Executive Officer at Caldera Therapeutics.
Where is Caldera Therapeutics headquartered?
Caldera Therapeutics is based in Cambridge, United States.
How many employees does Caldera Therapeutics have?
Caldera Therapeutics is in the 1-10 employee band.
When was Caldera Therapeutics founded?
Caldera Therapeutics was founded in 2025.
About FundedIQ's Caldera Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Caldera Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.